118 related articles for article (PubMed ID: 26214629)
21. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y; Wang X; Zhang W; Gong S
Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
[TBL] [Abstract][Full Text] [Related]
23. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
[TBL] [Abstract][Full Text] [Related]
24. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
[TBL] [Abstract][Full Text] [Related]
25. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
26. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
27. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
Francisco G; Menezes PR; Eluf-Neto J; Chammas R
Eur J Hum Genet; 2008 Jun; 16(6):724-34. PubMed ID: 18285822
[TBL] [Abstract][Full Text] [Related]
28. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
29. IGFBP-3 A-202C and C2133G polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Xu J; Xu L; Li LT; You Q; Cha LS
Genet Mol Res; 2015 Apr; 14(2):3370-86. PubMed ID: 25966104
[TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of the association between MS gene polymorphism and colorectal cancer risk.
Yang J; Zhong H; Yang H; Liu H; Ma L
Cell Biochem Biophys; 2014 Dec; 70(3):1943-9. PubMed ID: 25077679
[TBL] [Abstract][Full Text] [Related]
31. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
32. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
[TBL] [Abstract][Full Text] [Related]
33. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
[TBL] [Abstract][Full Text] [Related]
34. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
Wang Y; Li Z; Liu N; Zhang G
Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
[TBL] [Abstract][Full Text] [Related]
35. Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-analysis.
Wang J; Shi D; Guo X; Zhang J; Yu S; Song J; Cao Z; Wang J; Ji M; Dong W
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):481-90. PubMed ID: 24685603
[TBL] [Abstract][Full Text] [Related]
36. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects.
Yu KD; Chen AX; Qiu LX; Fan L; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279
[TBL] [Abstract][Full Text] [Related]
37. XPC Lys939Gln polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians.
Ahmad Aizat AA; Siti Nurfatimah MS; Aminudin MM; Ankathil R
World J Gastroenterol; 2013 Jun; 19(23):3623-8. PubMed ID: 23801864
[TBL] [Abstract][Full Text] [Related]
38. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
39. NAT2 polymorphism and lung cancer risk: a meta-analysis.
Cui D; Wang Z; Zhao E; Ma J; Lu W
Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
[TBL] [Abstract][Full Text] [Related]
40. Glutathione S-transferase T1 gene polymorphism and colorectal cancer risk: an updated analysis.
Qin XP; Zhou Y; Chen Y; Li NN; Chen B; Yang P; Wu XT
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):626-35. PubMed ID: 23773486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
